Patients with a known comorbid autoimmune disorder at the time of evaluation (e.g., SLE, IBD) were more likely to have elevated NfL levels in the CSF, which is congruent with being a biomarker for cerebral involvement in patients with SLE [49, 50]. The gene discussed is NEFL; the disease is systemic lupus erythematosus.